US Patent Issued to Inventprise on Sept. 15 for "Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24F" (Washington Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,229, issued on Sept. 15, was assigned to Inventprise Inc. (Redmond, Wash.).

"Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24F" was invented by Subhash V. Kapre (Redmond, Wash.) and Anup K. Datta (Renton, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention is directed to multivalent pneumococcal glycoconjugate compositions containing a newly emerging serotype of S. pneumonia, polysaccharide 24F, and their manufacture and use. The pneumococcal serotype 24F contains a polysaccharide repeating unit structure. The multivalent immunogenic composition comprises at least 25 S. pneumonia capsular polysaccharid...